This
page
is
part
of
the
Continuous
Integration
Build
of
FHIR
Specification
(v5.0.0:
R5
-
STU
).
This
is
the
current
published
version
in
it's
permanent
home
(it
will
always
(will
be
available
incorrect/inconsistent
at
this
URL).
For
a
full
list
of
available
versions,
see
times).
See
the
Directory
of
published
versions
.
Page
versions:
R5
R4B
R4
R3
| Responsible Owner: Pharmacy Work Group | Standards Status : Informative | Compartments : Encounter , Group , Patient , Practitioner |
This is the narrative for the resource. See also the XML , JSON or Turtle format. This example conforms to the profile MedicationRequest .
Generated Narrative: MedicationRequest medrx0306
identifier
:
id: 12345689 (use: OFFICIAL)
http://www.bmc.nl/portal/prescriptions
/12345689 (use: official, )
status
:
active
Active
intent
:
order
Order
| Reference |
|
|
subject
:
Patient/pat1:
Donald
Duck
"Donald
DUCK"
authoredOn : 2015-01-15
requester
:
Practitioner/f007:
Patrick
Pump
"Simone
HEPS"
| Concept |
|
Chronic
myeloid
|
dosageInstruction
sequence : 1
text : 6 mg PO daily for remission induction; adjust dosage to white blood cell (WBC) count. With hold treatment if WBC is less than 15,000/µL; resume when WBC is greater than 50,000/µL
timing : Once per 1
daysdayroute : Oral route (qualifier value)
( SNOMED CT #26643006)DoseAndRates
doseAndRateTypeDose[x] Ordered 6 mg (Details: UCUM codemg = 'mg')
Generated Narrative: Medication #med0304
MedicationAdministration/Oral ChemoMedicationDispense/Oral Chemocode : Myleran 2mg tablet, film coated
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.